Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.5M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
60.8M
-
Shares change
-
-713K
-
Total reported value, excl. options
-
$4.01B
-
Value change
-
-$46.7M
-
Put/Call ratio
-
3.61
-
Number of buys
-
90
-
Number of sells
-
-106
-
Price
-
$65.85
Significant Holders of Arcellx, Inc. - COMMON STOCK (ACLX) as of Q2 2025
241 filings reported holding ACLX - Arcellx, Inc. - COMMON STOCK as of Q2 2025.
Arcellx, Inc. - COMMON STOCK (ACLX) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.8M shares
.
Largest 10 shareholders include GILEAD SCIENCES, INC. (6.72M shares), FMR LLC (5.97M shares), Paradigm Biocapital Advisors LP (4.65M shares), VANGUARD GROUP INC (3.94M shares), NEA Management Company, LLC (3.75M shares), BlackRock, Inc. (3.47M shares), RA CAPITAL MANAGEMENT, L.P. (3.04M shares), Vestal Point Capital, LP (2.75M shares), PERCEPTIVE ADVISORS LLC (2.48M shares), and SR One Capital Management, LP (2.35M shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.